GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pentixapharm Holding AG (XTER:PTP) » Definitions » Other Current Liabilities

Pentixapharm Holding AG (XTER:PTP) Other Current Liabilities : €6.24 Mil (As of Jun. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Pentixapharm Holding AG Other Current Liabilities?

Pentixapharm Holding AG's other current liabilities for the quarter that ended in Jun. 2024 was €6.24 Mil.

Pentixapharm Holding AG's quarterly other current liabilities increased from Jun. 2023 (€0.00 Mil) to Dec. 2023 (€6.80 Mil) but then declined from Dec. 2023 (€6.80 Mil) to Jun. 2024 (€6.24 Mil).

Pentixapharm Holding AG's annual other current liabilities increased from Dec. 2021 (€0.10 Mil) to Dec. 2022 (€1.63 Mil) and increased from Dec. 2022 (€1.63 Mil) to Dec. 2023 (€6.80 Mil).


Pentixapharm Holding AG Other Current Liabilities Historical Data

The historical data trend for Pentixapharm Holding AG's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pentixapharm Holding AG Other Current Liabilities Chart

Pentixapharm Holding AG Annual Data
Trend Dec21 Dec22 Dec23
Other Current Liabilities
0.10 1.63 6.80

Pentixapharm Holding AG Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24
Other Current Liabilities 0.10 1.63 - 6.80 6.24

Pentixapharm Holding AG Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.


Pentixapharm Holding AG Other Current Liabilities Related Terms

Thank you for viewing the detailed overview of Pentixapharm Holding AG's Other Current Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Pentixapharm Holding AG Business Description

Traded in Other Exchanges
Address
Robert-Rossle-Street 10, Berlin, DEU
Pentixapharm Holding AG is a clinical-stage biopharmaceutical company active in the field of research and development of radiopharmaceuticals for diagnostic and therapeutic applications. Radiopharmaceuticals are medical substances containing radioactive elements used in nuclear medicine to diagnose or treat diseases. Its clinical pipeline encompasses PentixaTher, a Yttrium-90 based therapeutic against non-Hodgkin lymphomas (NHL), and PentixaFor, a Gallium-68-based companion diagnostic.

Pentixapharm Holding AG Headlines

No Headlines